Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia

Bone

Volumn 38, Issue 6, 2006, Pages 888-892

  Napoli, N ^a   Carmina, Enrico ^a   Bucchieri, Salvatore ^a   Sferrazza, C ^a   Rini, G B ^a   Di Fede, G ^a  

^a Dipartimento di Medicina Clinica e delle Patologie Emergenti   (Italy)

Author keywords

Iron overload; Osteopenia; Osteoporosis; Thalassemia major; Vitamin D

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CALCIFEDIOL; FERRITIN; PARATHYROID HORMONE;

ADULT; AGE DISTRIBUTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD TRANSFUSION; BONE DENSITY; BONE MASS; CALCIUM URINE LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM; THALASSEMIA; THALASSEMIA INTERMEDIA; THALASSEMIA MAJOR; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; BONE DENSITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; THALASSEMIA; VITAMIN D;

EID: 33749343758     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.11.018     Document Type: Article

References (27)

1. Orvieto R., Leichter I., Rachmilewitz A., and Margulies J.Y. Bone density, mineral content, and cortical index in patients with thalassaemia major and the correlation to their bone fractures, blood transfusions, and treatment with desferrioxamine. Calcif. Tissue Int. 50 (1992) 397-399
2. Jensen C.E., Tuck S.M., Agnew J.E., et al. High prevalence of low bone mass in thalassaemia major. Br. J. Haematol. 103 (1998) 901-915
3. Voskaridou E., Kyrtsonis M.C., Terpos E., et al. Bone resorption is increased in young adults with thalassaemia major. Br. J. Haematol. 112 (2001) 36-41
4. Pollack D.R., Rachmilewitz E., Blumenfeld A., Idelson M., and Goldfarb A.W. Bone mineral metabolism in adults with beta-thalassaemia major and intermedia. Br. J. Haematol. 111 3 (2000 (Dec)) 902-907
5. Wang C., Tso S.C., and Todd D. Hypogonadotropic hypogonadism in severe β-thalassaemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy. J. Clin. Endocrinol. Metab. 68 (1989) 511-516
6. Anapliotou M.L., Kastanias I.T., Psara P., et al. The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches. Clin. Endocrinol. 42 (1995) 279-287
7. Lasco A., Morabito N., Gaudio A., et al. Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassaemia major. Osteoporos. Int. 12 (2001) 570-575
8. Carmina E., Di Fede G., Napoli N., et al. Influence of hypogonadism and prolonged hormone replacement therapy on bone mass in adult women with thalassaemia major. Calcif. Tisssue Int. 74 1 (2004) 68-71
9. Giardina P.J., Schneider R., Lesser M., et al. Abnormal bone metabolism in thalassaemia. In: Ando S., et al. (Ed). Endocrine disorders in thalassaemia (1995), Springer, Berlin, Germany 39
10. Rioja L., Girot R., Garabedian M., et al. Bone disease in children with homozygous b-thalassaemia. Bone Miner. 8 (1990) 69-86
11. de Vernejoul M.C., Girot R., Gueris J., Cancela L., Bang S., Bielakoff J., et al. Calcium phosphate metabolism and bone disease in patients with homozygous thalassemia. J. Clin. Endocrinol. Metab. 54 2 (1982 (Feb)) 276-281
12. Pratico G., Di Gregorio F., Caltabiano F., et al. Calcium-phosphate metabolism in thalassaemia. Pediatr. Med. Chir. 20 (1998) 265-268
13. Zaino E.C., Yeh J.K., and Aloia J. Defective vitamin D metabolism in thalassemia major. Ann. N. Y. Acad. Sci. 445 (1985) 127-134
14. Dandona P., Menon R.K., Houlder S., Thomas M., Hoffbrand A.V., and Flynn D.M. Serum 1,25 dihydroxyvitamin D and osteocalcin concentrations in thalassaemia major. Arch. Dis. Child. 62 5 (1987 (May)) 474-477
15. Moulas A., Challa A., Chaliasos N., and Lapatsanis P.D. Vitamin D metabolites (25-hydroxyvitamin D, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D) and osteocalcin in beta-thalassaemia. Acta Paediatr. 86 6 (1997 (Jun)) 594-599
16. Chow L.H., Frei J.V., Hodsman A.B., and Valberg L.S. Low serum 25-hydroxyvitamin D in hereditary hemochromatosis: relation to iron status. Gastroenterology 88 4 (1985 (Apr)) 865-869
17. Chapuy M.C., Preziosi P., Maamer M., Arnaud S., Galan P., Hercberg S., et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos. Int. 7 5 (1997) 439-443
18. Malabanan A., Veronikis I.E., and Holick M.F. Redefining vitamin D insufficiency. Lancet 351 9105 (1998 (Mar 14)) 805-806
19. Heaney R.P. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am. J. Clin. Nutr. 80 Suppl. 6 (2004 (Dec)) 1706S-1709S
20. Chern J.P., and Lin K.H. Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J. Pediatr. Hematol. Oncol. 24 4 (2002 (May)) 291-293
21. Shamshirsaz A.A., Bekheirnia M.R., Kamgar M., Pourzahedgilani N., Bouzari N., Habibzadeh M., et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr. Disord. 3 1 (2003 (Aug 12)) 4
22. Brezis M., Shalev O., Leibel B., Dagan I., and Ben-Ishay D. The spectrum of parathyroid function in thalassaemia subjects with transfusional iron overload. Miner. Electrolyte Metab. 8 6 (1982 (Dec)) 307-313
23. Holick M.F., Matsuoka L.Y., and Wortsman J. Age, vitamin D, and solar ultraviolet. Lancet 2 8671 (1989 (Nov 4)) 1104-1105
24. Need A.G., Morris H.A., Horowitz M., and Nordin C. Effects of skin thickness age, body fat, and sunlight on serum 25-hydroxyvitamin D. Am. J. Clin. Nutr. 58 6 (1993 (Dec)) 882-885
25. Stamp T.C.B., and Round J.M. Seasonal changes in human plasma levels of 25-hydroxyvitamin D. Nature 247 (1974) 1563-1565
26. Domrongkitchaiporn S., Sirikulchayanonta V., Angchaisuksiri P., Stitchantrakul W., Kanokkantapong C., and Rajatanavin R. Abnormalities in bone mineral density and bone histology in thalassemia. J. Bone Miner. Res. 18 9 (2003 (Sep)) 1682-1688
27. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence?. Br. J. Nutr. 89 5 (2003 (May)) 552-572